Drug Use by Athletes

  • James C. Puffer


Until recently many believed that the use of drugs by athletes was not a problem. Nothing seemed more antithetical to the nature of true sport than using artificial means to attempt to improve performance. However, the financial rewards for success have increased, and the unrealistic expectations of a public obsessed with winning have been brought to bear on increasing numbers of athletes. As a result, many have turned to the use of performance-enhancing substances in an effort to gain unfair advantage over their competitors. The detection of an anabolic steroid (stanozolol) in the urine of Canadian sprinter Ben Johnson at the 1988 Summer Olympic games as well as the cocaine-related deaths of Maryland basketball player Len Bias and Cleveland Browns football player Don Rogers dramatically underscored the problems facing athletics when premier athletes turn to drugs to either enhance performance or escape the pressures of competing in sports. Both of these issues deserve to be explored, but this chapter focuses solely on the use of performance-enhancing drugs by athletes.


Drug Testing Anabolic Steroid Olympic Game International Olympic Committee National Collegiate Athletic Association 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Puffer JC. The use of drugs in swimming. Clin Sports Med 1986;5(1):77–89.PubMedGoogle Scholar
  2. 2.
    Duda M. Drug testing challenges: college and pro athletes. Phys Sports Med 1983;11(6):64–7.Google Scholar
  3. 3.
    Clement DB. Drug use survey: results and conclusions. Phys Sports Med 1983;11(9):64–7.Google Scholar
  4. 4.
    Anderson WA, McKeag DB. The substance use and abuse habits of college student athletes. Mission, KS: National Collegiate Athletic Association, 1985.Google Scholar
  5. 5.
    Cowart V. Steroids in sports: after four decades, time to return these genies to bottle? JAMA 1987;257:421–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Buckley WE, Yesalis CE, Friedl KE, et al. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 1988;260:3441–5.PubMedCrossRefGoogle Scholar
  7. 7.
    American College of Sports Medicine. Stand on the use of anabolic-androgenic steroids in sports. Indianapolis: American College of Sports Medicine, 1984.Google Scholar
  8. 8.
    Pope HG, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 1988;145:487–90.PubMedGoogle Scholar
  9. 9.
    Brower KJ, Blow FC, Beresford TP, et al. Anabolic-androgenic steroid dependence. J Clin Psychiatry 1989;50:31–3.PubMedGoogle Scholar
  10. 10.
    Macintyre JG. Growth hormone and athletes. Sports Med 1987;4:129–42.PubMedCrossRefGoogle Scholar
  11. 11.
    Crist DM, Peake GT, Egan PA, Water DL. Body composition response to exogenous GH during training in highly conditioned adults. J Appl Physiol 1988;65:579–84.PubMedGoogle Scholar
  12. 12.
    Ad Hoc Committee on Growth Hormone Usage, the Lawson Wil-kins Pediatric Endocrine Society, and the Committee on Drugs. Growth hormone in the treatment of children with short stature. Pediatrics 1983;72:891–4.Google Scholar
  13. 13.
    Smith GM, Beecher HK. Amphetamine sulphate and athletic performance. JAMA 1959;170:542–7.CrossRefGoogle Scholar
  14. 14.
    Chandler JV, Blair SN. The effects of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc 1980;12:65–9.PubMedGoogle Scholar
  15. 15.
    Mandell AJ. The Sunday syndrome: a unique pattern of amphetamine use indigenous to American professional football. Clin Toxicol 1979;15:225–32.PubMedCrossRefGoogle Scholar
  16. 16.
    Cregler L, Mark H. Medical complications of cocaine abuse. N Engl J Med 1986;315:1495–500.PubMedCrossRefGoogle Scholar
  17. 17.
    Giammarco RA. The athlete, cocaine, and lactic acidosis: a hypothesis. Am J Med Sci 1987;294:412–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Laurin CA, Letorneau G. Medical report on the Montreal Olympic Games. Am J Sports Med 1978;6:54–61.PubMedCrossRefGoogle Scholar
  19. 19.
    Butts NK, Crowell D. Effect of caffeine ingestion on cardiorespiratory endurance in men and women. Res Q Exerc Sport 1985;56: 301–5.CrossRefGoogle Scholar
  20. 20.
    Casal DC, Leon AS. Failure of caffeine to affect substrate utilization during prolonged running. Med Sci Sports Exerc 1985; 17: 174–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Ivy JL, Costill DL, Fink WJ, et al. Role of caffeine and glucose ingestion on metabolism during exercise. Med Sci Sports Exerc 1978;10:66.Google Scholar
  22. 22.
    Welch JM, Aubier M, Jardin M, et al. Effect of caffeine on skeletal muscle function before and after fatigue. J Appl Physiol 1983; 54:1303–5.Google Scholar
  23. 23.
    Sidney KH, Lefoe NM. The effects of Tedral upon athletic performance: a double-blind cross-over study. Quebec: Quebec City International Congress of Physical Activity Sciences, 1976.Google Scholar
  24. 24.
    DeMeersman R, Getty D, Schaefer DC. Sympathomimetics and exercise enhancement: all in the mind? Pharmacol Biochem Behav 1987;28:361–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Signorile JF, Kaplan JA, Applegate B, Perry AC. Effects of acute inhalation of the bronchodilater, albuterol, on power output. Med Sci Sports Exerc 1992;24:638–42.PubMedGoogle Scholar
  26. 26.
    Pace N, Lozner EL, Consolazio WV, et al. The increase in hypoxia tolerance of normal men accompanying the polycythemia induced by transfusion of erythrocytes. Am J Physiol 1947; 148:152–63.PubMedGoogle Scholar
  27. 27.
    Ersler AJ. Erythropoietin. N Engl J Med 1991;324:1339–44.CrossRefGoogle Scholar
  28. 28.
    Pate RR, Smith PE, Lambert MI, et al. Effect of orally administered sodium bicarbonate on performance of high intensity exercise. Med Sci Sports Exerc 1985;17:200–1.Google Scholar
  29. 29.
    Cade R, Conte M, Zauner C, et al. Effects of phosphate loading on 2,3-diphosphoglycerate and maximal oxygen uptake. Med Sci Sports Exerc 1984;16:263–8.PubMedGoogle Scholar
  30. 30.
    Hansen HJ, Caudill SP, Boone DJ. Crisis in drug testing: results of CDC blind study. JAMA 1985;253:2382–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Falk O, Palonek E, Bjorkhem I. Effect of ethanol on the ratio between testosterone and epitestosterone in urine. Clin Chem 1988;34:1482–4.Google Scholar
  32. 32.
    Summary report of drug screening questionnaire. Mission, KS: National Collegiate Athletic Association, 1986.Google Scholar
  33. 33.
    Abdenour TE, Miner MJ, Weir N. Attitudes of intercollegiate football players toward drug testing. Athletic Train 1987;22:199–201.Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • James C. Puffer

There are no affiliations available

Personalised recommendations